How have VAPO shares performed in 2024?

Vapotherm's stock was trading at $1.00 at the beginning of 2024. Since then, VAPO stock has increased by 36.0% and is now trading at $1.36. View the best growth stocks for 2024 here .

When is Vapotherm's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 1st 2024. View our VAPO earnings forecast .

How were Vapotherm's earnings last quarter?

Vapotherm, Inc. (NYSE:VAPO) released its quarterly earnings data on Thursday, February, 22nd. The company reported ($1.60) earnings per share for the quarter. The firm earned $19.73 million during the quarter.

When did Vapotherm's stock split?

Vapotherm's stock reverse split before market open on Friday, August 18th 2023. The 1-8 reverse split was announced on Friday, August 18th 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, August 18th 2023. An investor that had 100 shares of stock prior to the reverse split would have 13 shares after the split.

What is Joe Army's approval rating as Vapotherm's CEO?

65 employees have rated Vapotherm Chief Executive Officer Joe Army on Glassdoor.com . Joe Army has an approval rating of 93% among the company's employees. This puts Joe Army in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Vapotherm own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Vapotherm investors own include Advanced Micro Devices (AMD) , Pfizer (PFE) , Inovio Pharmaceuticals (INO) , NVIDIA (NVDA) , Micron Technology (MU) , Block (SQ) , Taiwan Semiconductor Manufacturing (TSM) , Synaptics (SYNA) , VBI Vaccines (VBIV) and

When did Vapotherm IPO?

Vapotherm (VAPO) raised $60 million in an initial public offering (IPO) on Wednesday, November 14th 2018. The company issued 4,000,000 shares at a price of $14.00-$16.00 per share. BofA Merrill Lynch and William Blair served as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.

How do I buy shares of Vapotherm?

Shares of VAPO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NYSE:VAPO

Vapotherm (VAPO) Stock Price, News & Analysis

→ Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad)

Free VAPO Stock Alerts

$1.36

0.00 (0.00%)

(As of 04/17/2024 ET)

Compare

Today's Range: $1.36
▼
$1.43
50-Day Range: $0.87
▼
$1.60
52-Week Range: $0.75
▼
$7.44

Volume: 1,113 shs
Average Volume: 9,596 shs
Market Capitalization: $8.43 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Get Vapotherm alerts:

Ad Tips4Traders

Uncover this 2024 Hidden Gem

Exclusive Report: Uncover a Hidden Investment Gem We’re excited to share a special report on one exceptional, publicly traded company. This company has achieved a remarkable 22+% just this year, outperforming the market and revealing the potential for significant gains.

[Click here to subscribe] and elevate your trading today.

About Vapotherm Stock (NYSE:VAPO)

Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally. The company offers High Velocity Therapy systems, such as HVT 2.0, Precision Flow Hi-VNI, Precision Flow Plus, and Precision Flow Classic which delivers non-invasive ventilatory support to patients by providing heated, humidified, and oxygenated air at a high velocity to treat patients through a small-bore nasal interface. It also provides companion products, including Vapotherm Transfer Unit, which allows patients to be transferred between care areas within the hospital or ambulate while on therapy; Q50 compressor that provides compressed air necessary to run the precision flow systems in areas of the hospital without access to a wall gas source; aerosol aeroneb adaptor to facilitate delivery of aerosolized solutions; aerosol disposable patient circuit that is designed to streamline the provision of continuous and intermittent delivery of aerosol solutions for patients; and tracheostomy adaptors that simplifies the connection of the High Velocity Therapy systems to a tracheostomy collar used to wean patients off mechanical ventilation. In addition, the company offers ProSoft cannula to provide gentle contact with the skin; and disposable products comprising single-use disposables and nasal interfaces, as well as Oxygen Assist Module, which helps clinicians maintain oxygen levels within a target range. Vapotherm, Inc. was founded in 1993 and is headquartered in Exeter, New Hampshire.

VAPO Stock Price History

30 days | 90 days | 365 days | Advanced Chart

VAPO Stock News Headlines

March 20, 2024 | msn.com

Vapotherm to debut home ventilator to improve patient care

March 20, 2024 | finance.yahoo.com

Onymos and Vapotherm Announce Partnership to Create an End-to-End Internet of Medical Things Solution (IoMT)

April 17, 2024 | Priority Gold (Ad)

Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!

Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.

March 15, 2024 | finance.yahoo.com

Vapotherm to Unveil Access365 Home Ventilation Solution at MEDTRADE

March 6, 2024 | prnewswire.com

Dr. David Yamane was awarded the Star Research Award at the 2024 Critical Care Congress for the presentation of the HYPERACT Study - a randomized controlled trial demonstrating Vapotherm's High Velocity Therapy effectively treats moderate-severe acute exacerbations of COPD, while improving patient comfort

February 29, 2024 | prnewswire.com

Vapotherm's HVT 2.0 System Overcomes Regulatory Hurdles for Entry into South America's Largest Health Care Market

February 23, 2024 | finanznachrichten.de

Vapotherm, Inc.: Vapotherm Reports Fourth Quarter and Fiscal Year 2023 Financial Results

February 22, 2024 | chron.com

Vapotherm: Q4 Earnings Snapshot

April 17, 2024 | Priority Gold (Ad)

Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!

Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.

February 22, 2024 | prnewswire.com

Vapotherm Reports Fourth Quarter and Fiscal Year 2023 Financial Results

December 15, 2023 | financialpost.com

OTC Markets Group Welcomes Vapotherm, Inc. to OTCQX

December 14, 2023 | finance.yahoo.com

NYSE to Commence Delisting Proceedings Against Vapotherm, Inc. (VAPO)

December 14, 2023 | marketwatch.com

Vapotherm Shares Suspended on NYSE, Company Previously Announced Voluntary Delisting Plan

December 11, 2023 | marketwatch.com

Vapotherm Shares Decline 22% on Voluntary Delisting Grom NYSE

December 11, 2023 | msn.com

Vapotherm slips on announcing voluntary delisting from NYSE to OTCQX Marketplace

December 11, 2023 | finance.yahoo.com

Vapotherm Announces Notification to New York Stock Exchange of Intention to Voluntarily Delist Common Stock Application Pending to Transfer Shares to OTCQX

November 28, 2023 | finance.yahoo.com

Vapotherm Educates over 8,000 Clinicians in Respiratory Care Month

November 10, 2023 | finance.yahoo.com

Vapotherm, Inc. (NYSE:VAPO) Q3 2023 Earnings Call Transcript

November 8, 2023 | msn.com

Vapotherm GAAP EPS of -$2.38 misses by $0.18, revenue of $15.2M misses by $1.52M

November 8, 2023 | finance.yahoo.com

Vapotherm Reports Third Quarter 2023 Financial Results

November 8, 2023 | uk.finance.yahoo.com

Vapotherm, Inc. (VAPO) stock price, news, quote & history – Yahoo Finance

November 7, 2023 | benzinga.com

Earnings Outlook For Vapotherm

November 1, 2023 | finance.yahoo.com

Vapotherm To Report Third Quarter 2023 Financial Results

October 4, 2023 | finance.yahoo.com

Computational Fluid Dynamics (CFD) modeling further distinguishes Vapotherm High Velocity Therapy from generic high flow cannulas

September 27, 2023 | marketwatch.com

Vapotherm Shares Jump on Positive Asthma Therapy Study

September 27, 2023 | benzinga.com

Vapotherm's Asthma Therapy More Effective Than Standard Oxygen Therapy In Kids

September 27, 2023 | markets.businessinsider.com

Vapotherm: Pilot Study Shows Effectiveness Of HVNI Technology In Children With Severe Asthma

See More Headlines

Receive VAPO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vapotherm and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 2/22/2024
Today: 4/17/2024
Next Earnings (Estimated): 5/01/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Sector: Medical
Industry: Surgical & medical instruments
Sub-Industry: N/A
Current Symbol: NYSE:VAPO
CUSIP: N/A
CIK: 1253176
Web: www.vapotherm.com
Phone: (866) 410-9986
Fax: N/A
Employees: 182
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($9.90)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-58,190,000.00
Net Margins: -84.74%
Pretax Margin: -84.56%
Return on Equity: N/A
Return on Assets: -65.84%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 2.43
Quick Ratio: 1.23

Sales & Book Value

Annual Sales: $68.67 million
Price / Sales: 0.12
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: ($9.01) per share
Price / Book: -0.15

Miscellaneous

Outstanding Shares: 6,200,000
Free Float: 5,221,000
Market Cap: $8.43 million
Optionable: Optionable
Beta: -1.11

Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

Mr. Joseph F. Army CPA (Age 60)
CEO, President & Director
Comp: $575k
Mr. John Landry (Age 51)
Senior VP, CFO & Treasurer
Comp: $593.38k
Mr. Brian Lawrence (Age 54)
Senior VP & CTO
Comp: $587.13k
Mr. William Niland
Founder
Ms. Dorota Mckay (Age 41)
VP, Controller & Chief Accounting Officer
Mr. Anthony Ten Haagen
Vice President of Legal & Compliance
Mr. James A. Lightman (Age 66)
Senior VP, General Counsel & Secretary
Ms. Lindsay Becker (Age 39)
Vice President of Human Resources
Dr. Jessica Whittle M.D.
Ph.D., Chief Medical Officer & VP of Clinical Research

Key Competitors

View All Competitors

Insiders

View All Insider Transactions

VAPO Stock Analysis - Frequently Asked Questions

How have VAPO shares performed in 2024?: Vapotherm's stock was trading at $1.00 at the beginning of 2024. Since then, VAPO stock has increased by 36.0% and is now trading at $1.36.
View the best growth stocks for 2024 here.
When is Vapotherm's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 1st 2024.
View our VAPO earnings forecast.
How were Vapotherm's earnings last quarter?: Vapotherm, Inc. (NYSE:VAPO) released its quarterly earnings data on Thursday, February, 22nd. The company reported ($1.60) earnings per share for the quarter. The firm earned $19.73 million during the quarter.
When did Vapotherm's stock split?: Vapotherm's stock reverse split before market open on Friday, August 18th 2023. The 1-8 reverse split was announced on Friday, August 18th 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, August 18th 2023. An investor that had 100 shares of stock prior to the reverse split would have 13 shares after the split.

What is Joe Army's approval rating as Vapotherm's CEO?: 65 employees have rated Vapotherm Chief Executive Officer Joe Army on Glassdoor.com. Joe Army has an approval rating of 93% among the company's employees. This puts Joe Army in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.
What other stocks do shareholders of Vapotherm own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Vapotherm investors own include Advanced Micro Devices (AMD), Pfizer (PFE), Inovio Pharmaceuticals (INO), NVIDIA (NVDA), Micron Technology (MU), Block (SQ), Taiwan Semiconductor Manufacturing (TSM), Synaptics (SYNA), VBI Vaccines (VBIV) and
When did Vapotherm IPO?: Vapotherm (VAPO) raised $60 million in an initial public offering (IPO) on Wednesday, November 14th 2018. The company issued 4,000,000 shares at a price of $14.00-$16.00 per share. BofA Merrill Lynch and William Blair served as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.
How do I buy shares of Vapotherm?: Shares of VAPO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:VAPO) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial